New injection technique may offer better knee pain relief

NCT ID NCT05235854

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether injecting a steroid (betamethasone) directly into the torn meniscus of the knee provides better pain relief and function than the standard injection into the joint space. 70 people with stable degenerative meniscal tears were randomly assigned to one of the two injection methods. The main goal was to see if the targeted injection improved knee function scores more at 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Betamethasone (a corticosteroid)

What this could lead to

If it works, this could offer a more targeted, longer-lasting injection for knee pain from meniscal tears, possibly delaying or avoiding surgery.

What could go wrong

This is a small, early-phase study (70 people) comparing two injection methods. The benefit may be small or not last long, and steroids have risks like cartilage damage or infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu Nimes

    Nîmes, 30029, France